INSTITUT CURIE;UNIVERSITE DE MONTPELLIER;ABIVAX;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
发明人:
Tazi, Jamal,Najman, Romain,Mahuteau, Florence,Scherrer, Didier,Chebli, Karim,Hahne, Michael
申请号：
AU2020200333
公开号：
AU2020200333A1
申请日:
2020.01.17
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020200333A120200206.pdf#####ABSTRACT The present invention relates to a compound of formula (I) Rn R'n' z Q N R" wherein: K z means an aromatic ring wherein V is C or N and when V is N； Q is N or 0, provided that R" does not exist when Q is 0； R' independently represent a hydrogen atom or a group chosen among a (C1-C3)alkyl group, a halogen atom, a hydroxyl group, a COOR 1 group, a -NO 2 group, a -NRiR2 group, a morpholinyl or a morpholino group, a Nmethylpiperazinyl group, a (C1-C3)fluoroalkyl group, a -O-P(=O)-(OR3)(OR 4) group, a (C1-C 4)alkoxy group and a -CN group, and can further be a group chosen among: Ra KAI B-N O Ra RbR (I1a) (lila) or anyone of its pharmaceutically acceptable salt, for use in the treatment and/or prevention of an inflammatory disease.
